McKesson, CD&R agree $5.8 billion purchase of Option Care Health

$32.05 a share is the key number: McKesson and investment firm CD&R have signed a deal to buy Option Care Health, which provides infusion therapy — medicine given by drip — for that price, about $5.8 billion in total. Announced October 6, 2026, according to CD&R. Shareholders get the per-share price; the total is approximate.